Share chart Outset Medical, Inc.
Extended chart
Simple chart
About Outset Medical, Inc.
Компания Medical, Inc., занимающаяся медицинскими технологиями, разрабатывает систему гемодиализа для диализа. Он предлагает Tablo, аппарат для диализа, который позволяет проводить диализную терапию в острых и хронических условиях. Tablo включает в себя компактную консоль с интегрированной очисткой воды, производством диализата по требованию, программным обеспечением и возможностями подключения. Компания ранее была известна как Home Dialysis Plus, Ltd. и в январе 2015 года сменила свое название на Earthless Medical, Inc. Компания Emergency Medical, Inc. more detailsIPO date | 2020-09-15 |
---|---|
ISIN | US6901451079 |
Industry | Health Care Equipment & Supplies |
Sector | Health Care |
Валюта | usd |
Валюта отчета | usd |
Див.доход ао | 0 |
Сайт | http://www.outsetmedical.com |
Цена ао | 0.9197 |
Change price per day: | -1.13% (0.86) |
---|---|
Change price per week: | +7.63% (0.79) |
Change price per month: | -24.75% (1.13) |
Change price per 3 month: | +56.31% (0.544) |
Change price per half year: | -75.77% (3.51) |
Change price per year: | -75.71% (3.5) |
Change price per 3 year: | -97.94% (41.21) |
Change price per 5 year: | +0% (0.8503) |
Change price per 10 year: | +0% (0.8503) |
Change price per year to date: | -23.4% (1.11) |
|
Underestimation
|
Efficiency
|
|||||||||||||||||||||||||||||||||||||
Dividends
|
Debt
|
Growth impulse
|
Transaction date | Date of disclosure | Insider | Type | Price | Volume | Quantity | Share before, % | Share after, % | Document |
---|---|---|---|---|---|---|---|---|---|
21.01.2025 | 22.01.2025 | Brottem John L. General Counsel |
Sale | 0.8 | 26 344 | 32930 | 0 | -0.07 | link |
21.01.2025 | 22.01.2025 | Nash Marc SVP Operations and R&D |
Sale | 0.8 | 18 577 | 23221 | 0 | -0.05 | link |
21.01.2025 | 22.01.2025 | Trigg Leslie Chair and CEO |
Sale | 0.8 | 52 189 | 65236 | 0 | -0.14 | link |
21.01.2025 | 21.01.2025 | Ahmed Nabeel Officer |
Purchase | 0.8 | 27 430 | 34288 | 0 | 0.07 | link |
21.01.2025 | 21.01.2025 | Brottem John L. Officer |
Purchase | 0.8 | 26 344 | 32930 | 0 | 0.07 | link |
21.01.2025 | 21.01.2025 | Nash Marc Officer |
Purchase | 0.8 | 18 577 | 23221 | 0 | 0.05 | link |
21.01.2025 | 21.01.2025 | Trigg Leslie Officer |
Purchase | 0.8 | 52 189 | 65236 | 0 | 0.14 | link |
13.01.2025 | 13.01.2025 | Nash Marc Officer |
Purchase | 0.81 | 12 159 | 15011 | 0 | 0.03 | link |
13.01.2025 | 13.01.2025 | Trigg Leslie Officer |
Purchase | 0.81 | 26 914 | 33227 | 0 | 0.07 | link |
13.01.2025 | 13.01.2025 | Ahmed Nabeel Chief Financial Officer |
Sale | 0.81 | 23 515 | 29031 | 0 | -0.06 | link |
13.01.2025 | 13.01.2025 | Brottem John L. General Counsel |
Sale | 0.81 | 16 599 | 20492 | 0 | -0.04 | link |
13.01.2025 | 13.01.2025 | Nash Marc Officer |
Sale | 0.81 | 12 159 | 15011 | 0 | -0.03 | link |
13.01.2025 | 13.01.2025 | Trigg Leslie Officer |
Sale | 0.81 | 26 914 | 33227 | 0 | -0.07 | link |
07.01.2025 | 07.01.2025 | Ahmed Nabeel Officer |
Purchase | 1.29 | 2 367 | 1835 | 0 | 0 | link |
07.01.2025 | 07.01.2025 | Brottem John L. Officer |
Purchase | 1.29 | 2 028 | 1572 | 0 | 0 | link |
15.08.2024 | 15.08.2024 | Ahmed Nabeel Chief Financial Officer |
Sale | 0.84 | 3 336 | 3971 | 0 | -0.01 | link |
15.08.2024 | 15.08.2024 | Brottem John L. General Counsel |
Sale | 0.84 | 2 529 | 3011 | 0 | -0.01 | link |
15.08.2024 | 15.08.2024 | Nash Marc SVP Operations and R&D |
Sale | 0.84 | 1 086 | 1293 | 0 | 0 | link |
15.08.2024 | 15.08.2024 | Trigg Leslie Chair and CEO |
Sale | 0.84 | 4 459 | 5308 | 0 | -0.01 | link |
24.07.2024 | 24.07.2024 | Nash Marc SVP Operations and R&D |
Sale | 4.02 | 2 906 | 723 | 0 | 0 | link |
16.01.2024 | 17.01.2024 | Brottem John L. General Counsel |
Sale | 4.29 | 6 349 | 1480 | 0 | 0 | link |
16.01.2024 | 17.01.2024 | Nash Marc SVP Operations and R&D |
Sale | 429 | 290 862 | 678 | 0 | 0 | link |
16.01.2024 | 17.01.2024 | Porter Stacey L. Chief People Officer |
Sale | 4.29 | 3 295 | 768 | 0 | 0 | link |
16.01.2024 | 17.01.2024 | Racine Jean-Olivier Chief Technology Officer |
Sale | 4.29 | 3 102 | 723 | 0 | 0 | link |
16.01.2024 | 17.01.2024 | Trigg Leslie Chair and CEO |
Sale | 4.29 | 34 861 | 8126 | 0 | -0.02 | link |
16.01.2024 | 17.01.2024 | Williamson Steven S. Chief Commercial Officer |
Sale | 4.29 | 4 273 | 996 | 0 | 0 | link |
08.01.2024 | 08.01.2024 | Ahmed Nabeel Chief Financial Officer |
Sale | 5.49 | 58 792 | 10709 | 0 | -0.02 | link |
08.01.2024 | 08.01.2024 | Brottem John L. General Counsel |
Sale | 5.49 | 40 319 | 7344 | 0 | -0.02 | link |
08.01.2024 | 08.01.2024 | Porter Stacey L. Chief People Officer |
Sale | 5.49 | 26 165 | 4766 | 0 | -0.01 | link |
08.01.2024 | 08.01.2024 | Racine Jean-Olivier Chief Technology Officer |
Sale | 5.49 | 21 438 | 3905 | 0 | -0.01 | link |
08.01.2024 | 08.01.2024 | Trigg Leslie Chair and CEO |
Sale | 5.49 | 77 892 | 14188 | 0 | -0.03 | link |
08.01.2024 | 08.01.2024 | Williamson Steven S. Chief Commercial Officer |
Sale | 5.49 | 38 732 | 7055 | 0 | -0.01 | link |
01.09.2023 | 05.09.2023 | Ahmed Nabeel Chief Financial Officer |
Sale | 13.61 | 7 417 | 545 | 0 | 0 | link |
01.03.2023 | 02.03.2023 | Vazquez Martin Chief Operating Officer |
Sale | 22.33 | 111 650 | 5000 | 0 | -0.01 | link |
01.03.2023 | 02.03.2023 | Vazquez Martin Chief Operating Officer |
Purchase | 3.88 | 19 400 | 5000 | 0 | 0.01 | link |
01.03.2023 | 02.03.2023 | Trigg Leslie Chair and CEO |
Sale | 22.48 | 674 400 | 30000 | 0 | -0.06 | link |
01.03.2023 | 02.03.2023 | Trigg Leslie Chair and CEO |
Purchase | 3.88 | 116 400 | 30000 | 0 | 0.06 | link |
02.02.2023 | 02.03.2023 | Vazquez Martin Chief Operating Officer |
Sale | 30 | 585 000 | 19500 | 0 | -0.04 | link |
02.02.2023 | 02.03.2023 | Vazquez Martin Chief Operating Officer |
Purchase | 3.88 | 75 660 | 19500 | 0 | 0.04 | link |
01.02.2023 | 02.03.2023 | Vazquez Martin Chief Operating Officer |
Sale | 27.91 | 139 550 | 5000 | 0 | -0.01 | link |
01.02.2023 | 02.03.2023 | Vazquez Martin Chief Operating Officer |
Purchase | 3.88 | 19 400 | 5000 | 0 | 0.01 | link |
01.02.2023 | 02.02.2023 | Trigg Leslie Chair and CEO |
Sale | 28.06 | 841 800 | 30000 | 0 | -0.06 | link |
01.02.2023 | 02.02.2023 | Trigg Leslie Chair and CEO |
Purchase | 3.88 | 116 400 | 30000 | 0 | 0.06 | link |
01.12.2022 | 02.12.2022 | Trigg Leslie Chair and CEO |
Sale | 20.85 | 625 500 | 30000 | 0 | -0.06 | link |
01.12.2022 | 02.12.2022 | Trigg Leslie Chair and CEO |
Purchase | 3.88 | 116 400 | 30000 | 0 | 0.06 | link |
01.12.2022 | 02.12.2022 | Vazquez Martin Chief Operating Officer |
Sale | 20.85 | 104 250 | 5000 | 0 | -0.01 | link |
01.12.2022 | 02.12.2022 | Vazquez Martin Chief Operating Officer |
Purchase | 3.88 | 19 400 | 5000 | 0 | 0.01 | link |
25.10.2022 | 26.10.2022 | Porter Stacey L. Chief People Officer |
Sale | 15.02 | 1 968 | 131 | 0 | 0 | link |
19.07.2022 | 19.07.2022 | Ahmed Nabeel Chief Financial Officer |
Sale | 16.56 | 13 033 | 787 | 0 | 0 | link |
17.05.2022 | 17.05.2022 | Brottem John L. General Counsel |
Sale | 26.36 | 9 200 | 349 | 0 | 0 | link |
17.05.2022 | 17.05.2022 | Ahmed Nabeel Chief Financial Officer |
Sale | 26.36 | 3 163 | 120 | 0 | 0 | link |
17.05.2022 | 17.05.2022 | Porter Stacey L. Chief People Officer |
Sale | 26.36 | 2 768 | 105 | 0 | 0 | link |
17.05.2022 | 17.05.2022 | Trigg Leslie Chair and CEO |
Sale | 26.36 | 23 961 | 909 | 0 | 0 | link |
17.05.2022 | 17.05.2022 | Vazquez Martin Chief Operating Officer |
Sale | 26.36 | 6 801 | 258 | 0 | 0 | link |
18.04.2022 | 18.04.2022 | Brottem John L. General Counsel |
Sale | 43.25 | 104 449 | 2415 | 0 | -0.01 | link |
18.04.2022 | 18.04.2022 | Brottem John L. General Counsel |
Purchase | 9.48 | 22 894 | 2415 | 0 | 0.01 | link |
15.03.2022 | 15.03.2022 | Brottem John L. General Counsel |
Sale | 38.59 | 254 154 | 6586 | 0 | -0.01 | link |
15.03.2022 | 15.03.2022 | Brottem John L. General Counsel |
Purchase | 9.48 | 62 435 | 6586 | 0 | 0.01 | link |
09.03.2022 | 15.03.2022 | Porter Stacey L. Chief People Officer |
Sale | 41.72 | 17 356 | 416 | 0 | 0 | link |
25.01.2022 | 25.01.2022 | Williamson Steven S. Chief Commercial Officer |
Sale | 37.74 | 86 047 | 2280 | 0 | 0 | link |
Institutions | Volume | Share, % |
---|---|---|
FMR, LLC | 7066782 | 13.99 |
JP Morgan Chase & Company | 4961199 | 9.82 |
Vanguard Group Inc | 3941367 | 7.8 |
Morgan Stanley | 3868064 | 7.66 |
Blackrock Inc. | 3795419 | 7.51 |
T. Rowe Price Investment Management, Inc. | 3166747 | 6.27 |
Ameriprise Financial, Inc. | 2982490 | 5.91 |
Braidwell LP | 2400427 | 4.75 |
Bellevue Group AG | 1760134 | 3.49 |
Mubadala Investment Co PJSC | 1440601 | 2.85 |
ETF | Share, % | Profitability for 1 year, % | Dividends, % |
---|---|---|---|
iShares Micro-Cap ETF | 0.00764 | 17.09 | 1.54048 |
Invesco FTSE RAFI US 1500 Small-Mid ETF | 0.00211 | 17.58 | 1.75869 |
![]() |
0.0007 | 17.47 | 1.51433 |
![]() |
0.00005 | 24.86 | 1.43354 |
Head | Job title | Payment | Year of birth |
---|---|---|---|
Ms. Leslie L. Trigg | President, CEO & Chairman | 1.22M | 1971 (54 years) |
Mr. John L. Brottem | General Counsel & Secretary | 594.15k | 1975 (50 years) |
Nicole Shannon | Director of Marketing Communications | N/A | |
Dr. Michael Aragon M.D. | Chief Medical Officer | N/A | |
Mr. Nabeel Ahmed | Chief Financial Officer | 654.74k | 1976 (49 years) |
Mr. James S. Mazzola | Head of Investor Relations | N/A | |
Mr. Marc Nash | Senior Vice President of Operations and R&D | N/A | 1989 (36 years) |
Address: United States, San Jose, CA , 3052 Orchard Drive - open in Google maps, open in Yandex maps
Website: http://www.outsetmedical.com
Website: http://www.outsetmedical.com